Alpha Cognition Inc
ACOG5.560USD
+0.510+10.10%
收盘 12/19, 16:00（美东）报价延迟15分钟
90.35M总市值
亏损市盈率 TTM
关于 Alpha Cognition Inc 公司
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company's ZUNVEYL (benzgalantamine) product is a delayed release oral tablet formulation indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults. Its pre-clinical development programs include ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mTBI; ALPHA-0602; ALPHA-0702 & ALPHA-0802 (Progranulin and Progranulin GEM’s) for the treatment of neurodegenerative diseases including amyotrophic lateral sclerosis or Lou Gehrig’s disease and spinal muscular atrophy, and ALPHA-1062 for the treatment of acute pancreatitis.
Alpha Cognition Inc简介
公司代码ACOG
公司名称Alpha Cognition Inc
上市日期Jun 09, 2021
CEOMcfadden (Michael E)
员工数量52
证券类型Ordinary Share
年结日Jun 09
公司地址c/o 1200 - 750 West Pender Street
城市VANCOUVER
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Canada
邮编V6C 2T8
电话16045649244
网址https://www.alphacognition.com/
公司代码ACOG
上市日期Jun 09, 2021
CEOMcfadden (Michael E)
Alpha Cognition Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Len Mertz
Mr. Len Mertz
Independent Chairman of the Board
Independent Chairman of the Board
324.01K
+44.95%
Mr. Michael E Mcfadden
Mr. Michael E Mcfadden
Chief Executive Officer, Director
Chief Executive Officer, Director
14.14K
+22.61%
Dr. Robert Wills
Dr. Robert Wills
Independent Director
Independent Director
--
--
Mr. Henry Du
Mr. Henry Du
Interim Chief Financial Officer, Vice President - Finance and Accounting
Interim Chief Financial Officer, Vice President - Finance and Accounting
--
--
Ms. Lauren D'Angelo
Ms. Lauren D'Angelo
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kenneth A. (Ken) Cawkell
Mr. Kenneth A. (Ken) Cawkell
Corporate Secretary, Director
Corporate Secretary, Director
--
--
Mr. Rajeev (Rob) Bakshi
Mr. Rajeev (Rob) Bakshi
Independent Director
Independent Director
--
--
Mr. John Havens
Mr. John Havens
Independent Director
Independent Director
--
--
Mr. Phillip Mertz
Mr. Phillip Mertz
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Len Mertz
Mr. Len Mertz
Independent Chairman of the Board
Independent Chairman of the Board
324.01K
+44.95%
Mr. Michael E Mcfadden
Mr. Michael E Mcfadden
Chief Executive Officer, Director
Chief Executive Officer, Director
14.14K
+22.61%
Dr. Robert Wills
Dr. Robert Wills
Independent Director
Independent Director
--
--
Mr. Henry Du
Mr. Henry Du
Interim Chief Financial Officer, Vice President - Finance and Accounting
Interim Chief Financial Officer, Vice President - Finance and Accounting
--
--
Ms. Lauren D'Angelo
Ms. Lauren D'Angelo
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kenneth A. (Ken) Cawkell
Mr. Kenneth A. (Ken) Cawkell
Corporate Secretary, Director
Corporate Secretary, Director
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月18日 周二
更新时间: 11月18日 周二
持股股东
股东类型
持股股东
持股股东
占比
Opaleye Management Inc.
8.62%
Solas Capital Management, LLC
5.90%
AWM Investment Company, Inc.
5.04%
Besser (James E)
4.61%
Ikarian Capital LLC
4.35%
其他
71.47%
持股股东
持股股东
占比
Opaleye Management Inc.
8.62%
Solas Capital Management, LLC
5.90%
AWM Investment Company, Inc.
5.04%
Besser (James E)
4.61%
Ikarian Capital LLC
4.35%
其他
71.47%
股东类型
持股股东
占比
Hedge Fund
22.57%
Investment Advisor/Hedge Fund
10.85%
Individual Investor
9.64%
Investment Advisor
0.60%
Bank and Trust
0.02%
其他
56.31%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
44
7.40M
33.08%
+1.76M
2025Q3
44
5.64M
33.86%
-82.42K
2025Q2
36
5.72M
45.79%
-973.15K
2025Q1
27
6.72M
43.80%
-299.24K
2024Q4
26
7.38M
0.35%
+7.33M
2024Q3
2
18.97K
0.61%
--
2024Q2
3
18.97K
6.61%
-360.38K
2024Q1
3
379.34K
6.64%
-18.86K
2023Q4
3
379.34K
9.14%
--
2023Q3
3
379.34K
9.85%
--
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Solas Capital Management, LLC
1.28M
6.1%
-117.32K
-8.42%
Jun 30, 2025
AWM Investment Company, Inc.
1.10M
5.24%
--
--
Jun 30, 2025
Besser (James E)
1.00M
4.8%
+1.00M
--
Jan 15, 2025
Ikarian Capital LLC
917.87K
4.39%
-50.00K
-5.17%
Jun 30, 2025
Cable Car Capital LLC
869.00K
4.16%
+554.00
+0.06%
Jun 30, 2025
Cawkell (Kenneth Anthony)
358.12K
1.71%
+139.64K
+63.92%
Apr 22, 2025
Sphera Funds Management Ltd.
376.65K
1.8%
-220.34K
-36.91%
Jun 30, 2025
Mertz (Leonard Powell)
324.01K
1.55%
+100.48K
+44.95%
Apr 22, 2025
Boothbay Fund Management, LLC
263.48K
1.26%
-17.86K
-6.35%
Jun 30, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Alpha Cognition Inc的前五大股东是谁？
Alpha Cognition Inc 的前五大股东如下：
Solas Capital Management, LLC持有股份：1.28M，占总股份比例：6.10%。
AWM Investment Company, Inc.持有股份：1.10M，占总股份比例：5.24%。
Besser (James E)持有股份：1.00M，占总股份比例：4.80%。
Ikarian Capital LLC持有股份：917.87K，占总股份比例：4.39%。
Cable Car Capital LLC持有股份：869.00K，占总股份比例：4.16%。
Solas Capital Management, LLC持有股份：1.28M，占总股份比例：6.10%。
AWM Investment Company, Inc.持有股份：1.10M，占总股份比例：5.24%。
Besser (James E)持有股份：1.00M，占总股份比例：4.80%。
Ikarian Capital LLC持有股份：917.87K，占总股份比例：4.39%。
Cable Car Capital LLC持有股份：869.00K，占总股份比例：4.16%。
Alpha Cognition Inc的前三大股东类型是什么？
Alpha Cognition Inc 的前三大股东类型分别是：
Opaleye Management Inc.
Solas Capital Management, LLC
AWM Investment Company, Inc.
Opaleye Management Inc.
Solas Capital Management, LLC
AWM Investment Company, Inc.
有多少机构持有Alpha Cognition Inc(ACOG)的股份？
截至2025Q4，共有44家机构持有Alpha Cognition Inc的股份，合计持有的股份价值约为7.40M，占公司总股份的33.08%。与2025Q3相比，机构持股有所增加，增幅为-0.78%。
哪个业务部门对Alpha Cognition Inc的收入贡献最大？
在--，--业务部门对Alpha Cognition Inc的收入贡献最大，创收--，占总收入的--%。
